Tracer Targeting FAP PET Imaging in Patients

计划入组 20 人 · 首次发布于 2023 年 1 月 20 日

FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis

计划入组 150 人 · 首次发布于 2024 年 8 月 21 日

Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors

计划入组 30 人 · 首次发布于 2019 年 4 月 30 日

117Lu-BiOncoFAP

DARPin-conjugated radioligand therapy (solid tumor)

FAP-2286

Molecular Targeting Technologies, Inc.

United States

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

Actithera Appoints Radiopharmaceutical Veteran Dr. Darshan Dalal as Chief Medical Officer to Lead FAP-Targeting Therapy Development

Telix Pharmaceuticals Expands Radiopharmaceutical Portfolio with Strategic FAP-Targeting Acquisition

NUCLIDIUM Secures US Patent Protection for Copper-Based FAP-Targeting Radiotheranostics Platform